Insider · CIK 0001190121
Daniel R Passeri
ceoofficerdirector
Files at CUE (Cue Biopharma, Inc.). First filing Dec 18, 2024, latest Dec 18, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$31k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CUE: Cue Biopharma, Inc.
CUEOct 9, 2026 · close 27.66
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | CUE Cue Biopharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +450,000 | $0.00 | $0 | 450,000 | Mar 25, 2025 |
| Dec 16, 2024 | CUE Cue Biopharma, Inc. | POpen-market purchase Common Stock | +30,000 | $1.03 | $31k | 164,578 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.